MFDS
- Status: likely_approved
🇰🇷 sitagliptin and metformin in South Korea
sitagliptin and metformin (sitagliptin and metformin) regulatory status in South Korea.
Marketing authorisations
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
sitagliptin and metformin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is sitagliptin and metformin approved in South Korea?
Yes. MFDS has authorised it; MFDS has authorised it; MFDS has authorised it.
Who is the marketing authorisation holder for sitagliptin and metformin in South Korea?
University Medical Centre Ljubljana is the originator. The local marketing authorisation holder may differ — check the official source linked above.